Given the unique pharmacology of MDK-703, it may have utility in indications where its pharmacokinetics, lack of IL-7 neutralizing antibodies, and T-cell enhancing properties are beneficial, including oncology, anti-viral and other infectious disease, vaccine enhancement, and treatment of lymphopenia. This evidence concerns the gene IL7 and lymphopenia.